Illinois was able to get up to $ 23 million in agreements with a pharmaceutical company that supplies fuel to the national opioid crisis by using only the only practices to increase opioid prescriptions.
Attorney General KWAME Raoul said that a total of $ 720 million will be agreed to nine states with a contract with eight pharmaceutical companies.
Raoul said, “As long as the Illinois family continues to experience the fatal impact of opioid addiction, my office will continue to cooperate with other lawyers to hold a company responsible for the opioid crisis.
According to Raoul’s Office, Illinoi has collected about $ 500 billion nationwide nationwide.
The other states are California, Colorado, New York, North Carolina, Oregon, Tennessee, Utah and Virginia.
This manufacturer can divide the following amount from the state.
- MyLan (currently part of Viaatris): $ 284,447,916 for 9 years.
- Hikma: $ 95,818,293 for 1-4 years.
- Yangmu: $ 71,751,010 for 10 years.
- Apotex: $ 63,682,369 in a year.
- Indivior: $ 38,022,450 for 4 years.
- Sun: $ 30,992,087 for 1-4 years.
- Alvogen: $ 18,680,162 per year.
- Zydus: $ 14,859,220 a year.
Under this agreement, seven companies are forbidden to promote opioid products and create or sell products that contain more than 40 milligrams per pill. You should also actively monitor and report suspicious commands.
Virginia -based Indivior can sell and sell drugs that treat opioid use disorders, although they do not manufacture or sell opioid products for the next 10 years as they settle down.
In the state, you can get free pharmaceutical products or get cash instead of products.
According to the Federal Disease Control and Prevention Center, about 725,000 people died of overdose of opioids in the United States between 1999 and 2022.
